Related Experiment Video

Updated: Aug 8, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Clinical trials, immunosuppression and renal transplantation: new trends in design and analysis

Paul Landais1, Jean-Pierre Daures

  • 1Laboratoire de Biostatistique et d'Informatique Médicale, Hôpital Necker Enfants Malades, Faculté Paris 5, 149 rue de Sèvres, 75743 Paris Cedex 15, France. landais@necker.fr

Pediatric Nephrology (Berlin, Germany)
|August 20, 2002
PubMed

Insights

This study reviews clinical trial methodologies for renal transplant rejection, focusing on patient selection, endpoints, and statistical analysis. It emphasizes high-quality randomized controlled trials for advancing immunosuppressive therapies and reducing uncertainty.

Area of Science:

  • Nephrology and Transplant Medicine
  • Clinical Trial Methodology
  • Immunosuppression Research

Background:

  • Renal transplant rejection necessitates effective and less toxic immunosuppressive agents.
  • Existing clinical trial frameworks require methodological refinement for optimal control of rejection.

Purpose of the Study:

  • To present and discuss key methodological aspects of clinical trials in renal transplantation.
  • To guide the selection of patients, endpoints, and statistical approaches for robust trial design.
  • To explore strategies for enhancing trial efficiency and the integration of pharmacoeconomics and reporting standards.

Main Methods:

  • Discussion of patient selection criteria and study endpoints, including standardized histopathology.
  • Exploration of Bayesian and frequentist statistical approaches, P-values, and confidence intervals.
  • Review of strategies for sample size reduction, power enhancement, and analysis of complex data (e.g., correlated data, meta-analysis).

Main Results:

  • Standardized definitions for histopathology and chronic rejection are crucial for endpoint evaluation.
  • Advanced statistical methods, including intention-to-treat analysis and meta-analysis, improve data interpretation.
  • Pharmacoeconomics and adherence to reporting guidelines (CONSORT, QOROM) are essential for clinical decision-making and research integrity.

Conclusions:

  • High-quality randomized controlled trials remain the gold standard for reducing uncertainty in renal transplantation.
  • Observational studies complement RCTs within an evidence-based hierarchy.
  • Methodological rigor in clinical trials is paramount for the advancement of immunosuppressive therapies.

More Related Videos

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies06:38

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies

Published on: April 12, 2017

Murine Full-thickness Skin Transplantation07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...